The Biden administration announced Thursday that drug companies receiving research funding from HHS’ emergency response arm, the Administration for Strategic Preparedness and Response, will have to commit to a “fair price” – not more than they charge in other countries. Host Chelsea Cirruzzo talks with POLITICO health care reporter Robert King about the Biden administration's efforts to curb high prescription drug prices.
Why the forecast is cloudy for year-end health legislation
A clear and present danger
More infant RSV shots sent as winter nears
U.K. approves world’s first gene-editing therapy
Health policy fixes in flux without year-end omnibus spending bill
Connecticut’s solution to covering pricey weight-loss drugs
Will Florida be the exception for abortion-rights supporters?
GOP seeks 95 percent cut to Trumps AIDS program
Voters have their say on abortion restrictions
2023 Milken Future of Health summit takeaways
Finding a doula in New York just got easier
CDC panel recommends changing infection-control guidelines
Notable change in NY's approach to overdose prevention funding
Transparency concerns at drug pricing patient sessions
The ACA's open enrollment began this week: Here's what's new
Coming to terms with AI’s future role in health care
The future is here: AI in health care
Abortion on the ballot: What the Ohio vote means
Congress debates Biden’s nursing home staffing rules
Bernie Sanders' failed fight to lower drug prices in 2023
Create your
podcast in
minutes
It is Free